Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin

Endocrinology

Volumn 148, Issue 2, 2007, Pages 896-902

  Uchida, Hiroshi ^a   Maruyama, Tetsuo ^a   Ono, Masanori ^a   Ohta, Kuniaki ^a   Kajitani, Takashi ^a   Masuda, Hirotaka ^a   Nagashima, Takashi ^a   Arase, Toru ^a   Asada, Hironori ^a   Yoshimura, Yasunori ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; PLACENTA PROTEIN 14; PROGESTERONE; SMALL INTERFERING RNA; STEROID HORMONE; TRICHOSTATIN A; VORINOSTAT;

ADENOCARCINOMA; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MENSTRUAL CYCLE; MORPHOGENESIS; PRIORITY JOURNAL; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; ENDOMETRIAL NEOPLASMS; ENZYME INHIBITORS; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; OVARY; PREGNANCY PROTEINS; UP-REGULATION;

EID: 33846422034     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0896     Document Type: Article

References (30)

1. Archer SY, Hodin RA 1999 Histone acetylation and cancer. Curr Opin Genet Dev 9:171-174
2. Kouzarides T 1999 Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9:40-48
3. Minucci S, Pelicci PG 2006 Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38-51
4. Kim Y, Park H, Lim Y, Han I, Kwon HJ, Woods A, Oh ES 2003 Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene 22:826-830
5. Liu LT, Chang HC, Chiang LC, Hung WC 2003 Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63:3069-3072
6. McGarry LC, Winnie JN, Ozanne BW 2004 Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. Oncogene 23:5284-5292
7. Michaelis M, Michaelis UR, Fleming I, Suhan T, Cinatl J, Blaheta RA, Hoffmann K, Kotchetkov R, Busse R, Nau H, Cinatl Jr J 2004 Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 65:520-527
8. Rombouts K, Knittel T, Machesky L, Braet F, Wielant A, Hellemans K, De Bleser P, Gelman I, Ramadori G, Geerts A 2002 Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. J Hepatol 37:788-796
9. Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB 2006 Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-κB activation. J Biol Chem 281:5612-5622
10. Leng SL, Leeding KS, Gibson PR, Bach LA 2001 Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. Carcinogenesis 22:1625-1631
11. Lin KT, Yeh SH, Chen DS, Chen PJ, Jou YS 2005 Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. J Biomed Sci 12:803-813
12. Mori T, Kim J, Yamano T, Takeuchi H, Huang S, Umetani N, Koyanagi K, Hoon DS 2005 Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 65:1800-1807
13. Wilson AJ, Gibson PR 1997 Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology 113:487-496
14. Sakai N, Maruyama T, Sakurai R, Masuda H, Yamamoto Y, Shimizu A, Kishi I, Asada H, Yamagoe S, Yoshimura Y 2003 Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells. J Biol Chem 278:16675-16682
15. Uchida H, Maruyama T, Nagashima T, Asada H, Yoshimura Y 2005 Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 146:5365-5373
16. Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, Miyakawa I, Koeffler HP 2004 Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin Cancer Res 10:1141-1149
17. Nishida M 2002 The Ishikawa cells from birth to the present. Hum Cell 15:104-117
18. Yano H, Uchida H, Iwasaki T, Mukai M, Akedo H, Nakamura K, Hashimoto S, Sabe H 2000 Paxillin α and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proc Natl Acad Sci USA 97:9076-9081
19. Croxtall JD, Elder MG, White JO 1990 Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J Steroid Biochem 35:665-669
20. Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA, Parthasarathy S 2001 Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA 98:9265-9270
21. Vigne JL, Hornung D, Mueller MD, Taylor RN 2001 Purification and characterization of an immunomodulatory endometrial protein, glycodelin. J Biol Chem 276:17101-17105
22. Seppälä M, Taylor RN, Koistinen H, Koistinen R, Milgrom E 2002 Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401-430
23. Oehninger S, Coddington C, Hodgen G, Seppälä M 1995 Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 63:377-383
24. Okamoto N, Uchida A, Takakura K, Kariya Y, Kanzaki H, Riittinen L, Koistinen R, Seppälä M, Mori T 1991 Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 26:137-142
25. Rachmilewitz J, Riely G, Tykocinski M 1999 Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol 191:26-33
26. Arnold JT, Lessey BA, Seppälä M, Kaufman DG 2002 Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res 62:79-88
27. Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Butzow R, Koistinen R 2003 Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res 63:6258-6264
28. Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U 2005 Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases. Anticancer Res 25:1761-1764
29. Kämäräinen M, Seppälä M, Virtanen I, Andersson LC 1997 Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 77:565-573
30. Koistinen H, Seppälä M, Nagy B, Tapper J, Knuutila S, Koistinen R 2005 Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells. Am J Obstet Gynecol 193:1955-1960